TABLE OF CONTENTS
- Introduction
- Definition of HLA Typing Market
- Scope of the Report
- Methodology
- Executive Summary
- Market Overview
- Market Definition and Segmentation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porter's Five Forces Analysis
- PESTEL Analysis
- HLA Typing Market, By Technology:
- Molecular Assay Technologies
- PCR-based Molecular Assays
- Sequence-specific Primer-PCR
- Sequence-specific Oligonucleotide-PCR
- Other PCR-based Molecular Assays
- Sequencing-based Molecular Assays
- Sanger Sequencing
- Next-generation Sequencing
- Pyrosequencing
- Non-molecular Assay Technologies
- PCR-based Molecular Assays
- Molecular Assay Technologies
- HLA Typing Market, By Product & Service:
- Reagents & Consumables
- Instruments
- Software & Services
- HLA Typing Market, By Application:
- Diagnostic Applications
- Research Applications
- Donor-recipient cross-matching
- Infectious disease testing
- Cancer diagnosis & prevention
- Transfusion therapy
- Other diagnostic applications
- HLA Typing Market, By End User:
- Commercial service providers
- Hospitals & surgical centers
- Research laboratories & academic institutes
- HLA Typing Market, By Geography
- North America
- United States
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of Middle East & Africa
- North America
- Competitive Landscape
- Company Profiles
- Pacbio
- Company Overview
- Product Portfolio and Description
- Key Highlights
- Financial Overview
- F. Hoffman-La Roche Ltd.
- Alpha Biotech Limited
- Qiagen N.V.
- Caredx, Inc.
- Krishgen Biosystems
- HistogeneticsLlc
- Creative Biolabs
- Takara Bio Inc.
- Omixon Inc.
- Bio-Rad Laboratories, Inc.
- Inno-Train Diagnostik GMBH
- Hansa Biopharma Ab
- Thermo Fisher Scientific
- Immucor, Inc.
- BD
- TBG Diagnostics Limited
- GENDX
- Illumina, Inc.
- Bag Diagnostics Gmbh
- Fujirebio
- Biofortuna Limited
- Hologic, Inc.
- Pacbio
- Conclusion and Future Outlook
- Appendix
- Research Methodology
- About the Pharmanucleus
13. Disclaimer